Li Wang

Li Wang

Patrimonio netto: 27 M $ in data 31/05/2026

57 anni
Health Technology
Consumer Services
Commercial Services

Profilo

Li Wang is the founder of Shanghai AngioCare Medical Technology Co., Ltd. since 2011, holding the title of Director.
Mr. Wang is the founder of Shanghai Bio-Heart Biological Technology Co., Ltd. since 2014, holding the title of Chairman & Chief Executive Officer.
Former positions include Marketing Director at Medtronic, Inc., Marketing Director at Boston Scientific Corp., Director at Shanghai Kinetic Medical Co., Ltd. from 2013 to 2019, Executive Director & Manager at Essen Technology (Beijing) Co., Ltd. from 2013 to 2020, Manager at Guidant Corp., and Chief Operating & Marketing Officer at MicroPort Scientific Corp.
from 2002 to 2012.
Education includes undergraduate studies at the University of California, Berkeley, undergraduate degree conferred in 1993 from the University of California, Davis, and an MBA conferred in 1996 from the University of California, Davis.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValutazioneData di valutazione
09/06/2026 62.256.294 ( 26,41% ) 24 M $ 31/05/2026
30/06/2025 7.713.678 ( 3,27% ) 3 M $ 31/05/2026

Posizioni attive di Li Wang

SocietàPosizioneInizio
SHANGHAI BIO-HEART BIOLOGICAL TECHNOLOGY CO., LTD. Amministratore Delegato 18/07/2014
Fondatore 01/09/2011

Precedenti posizioni note di Li Wang

SocietàPosizioneFine
Presidente 01/12/2020
SHANGHAI KINETIC MEDICAL CO., LTD Direttore/Membro del Consiglio 01/04/2019
MICROPORT SCIENTIFIC CORPORATION Amministratore Delegato 01/01/2012
BOSTON SCIENTIFIC CORPORATION Vendite & Marketing -
Vendite & Marketing -
Vedi nel dettaglio l'esperienza di Li Wang

Formazione di Li Wang

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

86

Relazioni di 1° grado

10

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private10

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

-40% : Prolongation exceptionnelle ➤➤➤➤
g
:
:
ENTRA ORA